Clinical Trials Logo
  1. Home
  2. Myositis
  3. NCT01184625

Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation

Myositis Clinical Trial

Official title:
Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation

Clinical Trial Summary

The objectives of this study are to test if hypoxia in muscle tissue is an important factor contributing to clinical symptoms in chronic rheumatic muscle inflammation and to evaluate if a 12 week endurance exercise program will improve muscle tissue hypoxia and disability in patients with chronic rheumatic muscle inflammation.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01184625
Study type Interventional
Source Karolinska Institutet
Contact Ingrid E Lundberg, MD, PhD, Prof
Phone +46 8 517700
Email ingrid.lundberg@ki.se
Status Recruiting
Phase N/A
Start date January 2008
Completion date August 2012
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06284954 - A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis Phase 2
Completed NCT06300983 - Effectiveness of a Psychoeducational Intervention on Myositis Patients' Quality of Life and Well-Being N/A
Recruiting NCT05832034 - Add-on Intravenous Immunoglobulins in Early Myositis Phase 2
Recruiting NCT05979441 - A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy Phase 3
Active, not recruiting NCT02468895 - MYOPROSP - a Prospective Cohort Study in Myositis
Recruiting NCT01501019 - Exercise in Sjogren, Myositis and Takayasu's Arteritis N/A
Recruiting NCT05523167 - A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. Phase 2/Phase 3
Completed NCT03414086 - Predictor of Clinical Response to Acthar in Myositis
Not yet recruiting NCT01702870 - Diagnostic Accuracy of MR in Myositis N/A
Terminated NCT03937856 - Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases N/A
Completed NCT03440034 - Study of Pioglitazone in Sporadic Inclusion Body Myositis Phase 1
Recruiting NCT05895786 - A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] Phase 3
Completed NCT00001331 - Genetic and Family Studies of Inherited Muscle Diseases N/A
Terminated NCT04309227 - Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations N/A
Completed NCT03059394 - Validation of Rehab Assessments in Myositis Patients N/A
Completed NCT00106184 - Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) Phase 2
Recruiting NCT04367350 - Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement
Completed NCT01734369 - Environmental Risk Factors for Myositis in Military Personnel
Recruiting NCT02450396 - Pregnancy and Medically Assisted Conception in Rare Diseases
Recruiting NCT03912428 - Novel PET Radioligands as Inflammatory Biomarkers in Rheumatoid Arthritis and Myositis Phase 1